Connect Biopharma Holdings Ltd SEC filings CNTB
Connect Biopharma Holdings Ltd has 196 filings in SEC EDGAR's recent list, going back to Dec 17, 2020. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 1, 2026 | — |
| CORRESP | Letter to the SEC | May 28, 2026 | — |
| UPLOAD | Letter from the SEC | May 22, 2026 | — |
| EFFECT | Filing | Sep 12, 2025 | — |
| EFFECT | Filing | Jun 26, 2025 | — |
| CORRESP | Letter to the SEC | Jun 24, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2023 | — |
| CORRESP | Letter to the SEC | Jul 24, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2023 | — |
| EFFECT | Filing | Jul 6, 2022 | — |
| CORRESP | Letter to the SEC | Jul 1, 2022 | — |
| CORRESP | Letter to the SEC | Jun 17, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2022 | — |
| CORRESP | Letter to the SEC | May 20, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2022 | — |
| CERT | Filing | Mar 19, 2021 | — |
| EFFECT | Filing | Mar 18, 2021 | — |
| EFFECT | Filing | Mar 18, 2021 | — |
| CORRESP | Letter to the SEC | Mar 17, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2021 | — |
| CORRESP | Letter to the SEC | Mar 16, 2021 | — |
| CORRESP | Letter to the SEC | Mar 16, 2021 | — |
| 8-A12B | Filing | Mar 12, 2021 | — |
| CORRESP | Letter to the SEC | Mar 9, 2021 | — |
| CORRESP | Letter to the SEC | Mar 8, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2021 | — |
| DRSLTR | Filing | Feb 16, 2021 | — |
| DRS/A | Filing | Feb 16, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2021 | — |
| DRSLTR | Filing | Jan 26, 2021 | — |
| DRS/A | Filing | Jan 26, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2021 | — |
| DRSLTR | Filing | Dec 17, 2020 | — |
| DRS | Filing | Dec 17, 2020 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNTB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1835268
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.